Body HCA’s Compliance Program is responsible for ensuring organizational compliance with federal and state regulatory requirements. The Compliance Program establishes standards of compliance and ethical conduct for HCA staff, provides ongoing support and education, and offers a mechanism by which to report suspected violations. The Office of Compliance also works to... Links in this section relate to Body

Body AFFORDABLE CARE ACT (ACA) 45 CFR 92 SECTION 1557 The Orange County Health Care Agency complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. Orange County Health Care Agency does not exclude people or treat them...

Body Custodian of Records Newsletters Press Releases Publications

Body MSN Patient Resource Guide Nursing Seniors WIC Women's Cancer Links in this section relate to Body

Body CD Health Alert: FDA Approval of Pfizer BioNTech COVID-19 Vaccine for Ages 16 and Older August 24, 2021 Yesterday, August 23, 2021, the US Food and Drug Administration (FDA) approved the first COVID-19 vaccine. The Pfizer BioNTech COVID-19 vaccine, to be marketed under the name Comirnaty, is fully approved for...

Body Continue to new location.

Body Alcohol & Drug Abuse Services BHS System Metrics Crisis & Support Drug Medi-Cal Organized Delivery System (DMC-ODS) HCA Portal Navigation, Innovation & Training Policies and Procedures Practice Guidelines Prevention & Intervention Services Treatment Facilities Young Adults (18-25 yrs)

Body Authority & Quality Improvement Services CPSP Providers CYS QRT Training MSN Newsletters Reports School-wide Systems Violence Prevention

Body The OC Health Care Agency’s Environmental Health division has closed the bay water area from Bayside Drive Beach to China Cove due to a sewage spill. Read More Links in this section relate to Body

Body CDC has updated its recommendation for the treatment of uncomplicated gonorrhea in adults. Gonorrhea should now be treated with just one higher dose (500 mg) injection of ceftriaxone, and dual therapy is no longer the recommended approach.